Association of genetically predicted levels of circulating blood lipids with coronary artery disease incidence

被引:0
|
作者
Manikpurage, Hasanga D. [1 ]
Ricard, Jasmin [1 ]
Houessou, Ursula [1 ]
Bourgault, Jerome [1 ]
Gagnon, Eloi [1 ]
Gobeil, Emilie [1 ]
Girard, Arnaud [1 ]
Li, Zhonglin [1 ]
Eslami, Aida [1 ,2 ]
Mathieu, Patrick [1 ,3 ]
Bosse, Yohan [1 ,4 ]
Arsenault, Benoit J. [1 ,5 ]
Theriault, Sebastien [1 ,6 ]
机构
[1] Univ Laval, Ctr Rech Inst Univ Cardiol & Pneumol Quebec, C-2113,2725 Chemin Ste Foy, Quebec City, PQ G1V 4G5, Canada
[2] Univ Laval, Fac Med, Dept Social & Prevent Med, Quebec City, PQ, Canada
[3] Univ Laval, Fac Med, Dept Surg, Quebec City, PQ, Canada
[4] Univ Laval, Fac Med, Dept Mol Med, Quebec City, PQ, Canada
[5] Univ Laval, Fac Med, Dept Med, Quebec City, PQ, Canada
[6] Univ Laval, Fac Med, Dept Mol Biol Med Biochem & Pathol, Quebec City, PQ, Canada
关键词
Polygenic risk scores; Lipoproteins; Fatty acids; Nuclear magnetic resonance; Genetics; Coronary artery disease; Myocardial infarction; Coronary revascularization; Primary prevention; Risk stratification; COMPLEX TRAITS; RISK SCORE; CHOLESTEROL; VLDL; LDL;
D O I
10.1016/j.atherosclerosis.2024.119083
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aims: Estimating the genetic risk of coronary artery disease (CAD) is now possible by aggregating data from genome-wide association studies (GWAS) into polygenic risk scores (PRS). Combining multiple PRS for specific circulating blood lipids could improve risk prediction. Here, we sought to evaluate the performance of PRS derived from CAD and blood lipids GWAS to predict the incidence of CAD. Methods: This study included individuals aged between 40 and 69 from UK Biobank. We conducted GWAS for blood lipids measured by nuclear magnetic resonance in individuals without lipid-lowering treatments (n = 73,915). Summary statistics were used to derive PRS in the remaining participants (n = 318,051). A PRSCAD was derived using the CARDIoGRAMplusC4D GWAS. Hazard ratios (HR) for CAD (n = 9017 out of 301,576; median follow-up: 12.6 years) were calculated per standard deviation increase in each PRS. Models' discrimination capacity and goodness-of-fit were evaluated. Results: Out of 30 PRS, 27 were significantly associated with the incidence of CAD (p < 0.0017). The optimal combination of PRS included PRS for CAD, VLDL-C, total cholesterol and triglycerides. Discriminative capacities were significantly increased in the model including PRSCAD and clinical risk factors (CRF) (C-statistic = 0.778 [0.773-0.782]) compared to the model with CRF only (C-statistic = 0.755 [0.751-0.760], difference = 0.022 [0.020-0.025]). Although the C-statistic remained similar when independent lipids PRS were added to the model with PRSCAD and CRF (C-statistic = 0.778 [0.773-0.783]), the goodness-of-fit was significantly increased (chisquare test statistic = 20.18, p = 1.56e-04). Conclusions: Although independently associated with CAD incidence, blood lipids PRS provide modest improvement in the predictive performance when added to PRSCAD.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Analysis of Circulating Cholesterol Levels as a Mediator of an Association Between ABO Blood Group and Coronary Heart Disease
    Chen, Yequn
    Chen, Chang
    Ke, Xiayi
    Xiong, Longgen
    Shi, Yongying
    Li, Jiafu
    Tan, Xuerui
    Ye, Shu
    CIRCULATION-CARDIOVASCULAR GENETICS, 2014, 7 (01) : 43 - 48
  • [32] Genetically Predicted Circulating Levels of Antioxidants and Risk of Breast and Ovarian Cancer
    Zhao, Huanling
    Zhu, Jiahao
    Tse, Lap Ah
    Kinra, Sanjay
    Li, Yingjun
    CANCER PREVENTION RESEARCH, 2022, 15 (04) : 247 - 254
  • [33] Genetically Determined High Levels of Iron Parameters Are Protective for Coronary Artery Disease
    Beverborg, Niels Grote
    Said, M. Abdullah
    van der Wal, Haye H.
    Verweij, Niek
    van der Meer, Peter
    van der Harst, Pim
    CIRCULATION-GENOMIC AND PRECISION MEDICINE, 2020, 13 (01):
  • [34] Association of small dense LDL serum levels and circulating monocyte subsets in patients with stable coronary artery disease
    Krychtiuk, K. A.
    Kastl, S. P.
    Pongratz, T.
    Goliasch, G.
    Gaspar, L.
    Wojta, J.
    Dostal, E.
    Pfaffenberger, S.
    Oravec, S.
    Speidl, W. S.
    EUROPEAN HEART JOURNAL, 2014, 35 : 487 - 487
  • [35] Levels of activated FXII in survivors of myocardial infarction - Association with circulating risk factors and extent of coronary artery disease
    Kohler, HP
    Carter, AM
    Stickland, MH
    Grant, PJ
    THROMBOSIS AND HAEMOSTASIS, 1998, 79 (01) : 14 - 18
  • [36] THE PLASMA LIPIDS IN CORONARY ARTERY DISEASE
    OLIVER, MF
    BOYD, GS
    BRITISH HEART JOURNAL, 1953, 15 (04): : 387 - 392
  • [37] LIPIDS AND CORONARY-ARTERY DISEASE
    SALEL, AF
    MASON, DT
    ANNALS OF INTERNAL MEDICINE, 1976, 85 (03) : 393 - 393
  • [38] PLASMA LIPIDS AND CORONARY ARTERY DISEASE
    WENDT, VE
    DEHMLOW, C
    FIERENS, EE
    YOUNG, DG
    AMERICAN JOURNAL OF CARDIOLOGY, 1970, 25 (01): : 135 - &
  • [39] Serum calcium levels and its association with coronary artery disease
    Patel, Mansi A.
    Agrawal, Sachin Ratanlal
    Acharya, Sourya
    Kumar, Sunil
    JOURNAL OF THE SCIENTIFIC SOCIETY, 2022, 49 (03) : 256 - 259
  • [40] Association of Serum Cyclophilin A Levels with Severity of Coronary Artery Disease
    Manaswini, Namilakonda
    Sreedevi, Neelam N.
    Thummala, Sabitha
    Saibaba, Kompella S. S.
    Mohammed, Noorjahan
    Satish, Oruganti Sai
    JOURNAL OF LABORATORY PHYSICIANS, 2022, 14 (03) : 253 - 259